EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PREDICT‐ GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?

Victoria L Parker iD, Matthew C Winter, John A Tidy, Barry W Hancock, Julia E Palmer, Naveed Sarwar, Baljeet Kaur, Katie McDonald, Xianne Aguiar, Kamaljit Singh, Nick Unsworth, Imran Jabbar und 3 weitere

International Journal of Cancer · 2023-03 · 152 (5) · 986-997

DOI: 10.1002/ijc.34352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 03.12.2022. Verfasst von Victoria L Parker und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Metabolism, The Medical School, The University of Sheffield, Sheffield, UK. Hauptthemen laut MEDLINE: Gestational Trophoblastic Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health, Cancer Research UK, Weston Park Cancer Charity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight‐variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first‐line single‐agent chemotherapy resistance. FIGO is imperfect with one‐third of low‐risk patients developing disease resistance to first‐line single‐agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1‐6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland‐Altman calibration plots, decision curve analysis and contingency tables. M1‐6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55‐112 undertreated, 46‐206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment‐resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gestational Trophoblastic DiseasePregnancyFemaleHumansRetrospective StudiesModels, Statistical

Stichwörter der Autor:innen

FIGOgestational trophoblastic neoplasiascoring system

Autor:innen und Institutionen

  • Department of Oncology and Metabolism, The Medical School, The University of Sheffield, Sheffield, UK.
  • Sheffield Centre for Trophoblastic Disease, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Gestational Trophoblastic Disease Centre, Department of Medical Oncology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Department of Automatic Control and Systems Engineering, The University of Sheffield, Sheffield, UK.

ORCID-Profile: Victoria L Parker

Förderung

  • Department of Health
  • Cancer Research UK
  • Weston Park Cancer Charity
  • NIHR Imperial Biomedical Research Centre

Zitieren

APA

Parker, V. L., Winter, M. C., Tidy, J. A., Hancock, B. W., Palmer, J. E., Sarwar, N., Kaur, B., McDonald, K., Aguiar, X., Singh, K., Unsworth, N., Jabbar, I., Pacey, A. A., Harrison, R. F., & Seckl, M. J. (2023). PREDICT‐ GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?. International Journal of Cancer, 152(5), 986-997. https://doi.org/10.1002/ijc.34352

Vancouver

Parker VL, Winter MC, Tidy JA, Hancock BW, Palmer JE, Sarwar N, et al. PREDICT‐ GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?. International Journal of Cancer. 2023;152(5):986-997. doi:10.1002/ijc.34352

BibTeX
@article{Parker2023,
  author = {Parker, Victoria L and Winter, Matthew C and Tidy, John A and Hancock, Barry W and Palmer, Julia E and Sarwar, Naveed and Kaur, Baljeet and McDonald, Katie and Aguiar, Xianne and Singh, Kamaljit and Unsworth, Nick and Jabbar, Imran and Pacey, Allan A and Harrison, Robert F and Seckl, Michael J},
  title = {PREDICT‐ GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?},
  journal = {International Journal of Cancer},
  year = {2023},
  volume = {152},
  number = {5},
  pages = {986--997},
  doi = {10.1002/ijc.34352}
}
Kostenlos starten →